Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: the JLCA and JSHBPS Expert Consensus Statement 2023
Recent advances in systemic therapy for hepatocellular carcinoma (HCC) have led to debates about the feasibility of combination therapies, such as systemic therapy combined with surgery or transarterial chemoembolization, for patients with advanced HCC. However, a lack of consensus on the oncologica...
Main Authors: | Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, Shunichi Ariizumi, Susumu Eguchi, Yukiyasu Okamura, Masaki Kaibori, Shoji Kubo, Mitsuo Shimada, Akinobu Taketomi, Nobuyuki Takemura, Hiroaki Nagano, Masafumi Nakamura, Kiyoshi Hasegawa, Etsuro Hatano, Tomoharu Yoshizumi, Itaru Endo, Norihiro Kokudo |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-03-01
|
Series: | Liver Cancer |
Online Access: | https://beta.karger.com/Article/FullText/538627 |
Similar Items
-
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
by: Akihiko Ichida, et al.
Published: (2023-11-01) -
Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab
by: Masayuki Okuno, et al.
Published: (2023-08-01) -
Glycine Transporter Blockade Ameliorates Motor Ataxia in a Mouse Model of Spinocerebellar Atrophy
by: Mitsuo Tanabe, et al.
Published: (2009-01-01) -
Reply to “Surgical resection or radiofrequency ablation for small hepatocellular carcinoma”
by: Yoshikuni Kawaguchi, et al.
Published: (2023-03-01) -
Liver resection in a patient with persistent positive PCR test for coronavirus disease 2019 (COVID-19): a case report
by: Akiho Sugita, et al.
Published: (2022-10-01)